Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Amaresh Das

Amaresh Das

APHIS-USDA, USA

Title: Critical components of diagnostic real time polymerase chain reaction from sample preparation to extraction to amplification

Biography

Biography: Amaresh Das

Abstract

The real time polymerase chain reaction (qPCR) has now been widely used as one of the mainstream diagnostic assays for rapid detection of infectious diseases in animals due to its sensitivity and specificity. However, the interpretation of qPCR results can be challenging and must be interpreted in conjunction with the history, clinical signs and the evidence of disease. Performing qPCRassays involves multiple steps including sample preparation, nucleic acid extraction and amplification. Thisstudy aims at critical evaluation of each step based on our experience working with multiple animal disease viruses including avian influenza virus (AIV), classical swine virus (CSFV) and Capripoxvirus (CaPV). Diagnostic specimens were collected from experimentally and naturally infected animals including swabs (multiple types), blood and tissues (multiple types). Critical factors that influence the performance of qPCR include: inefficient release of the virus from specimens (sample preparation), co-purification of naturally occurring PCR inhibitors (extraction) and PCR failure (amplification). The foremost challenge has been the false negative results due to PCR inhibition. Indigenous (beta-actin) or exogenously addedcontrols (reverse transcribed RNA) were used to detect PCR inhibitors. The highest level of PCR inhibitorswere detected in fecal samples (AIV-infected specimens) followed by blood, tissues and swabs (AIV- and CSFV-infected specimens). Commercial extraction kits failed to completely remove PCR inhibitors from the clinical specimens. Commercial protocols were modified by adding an extra high-salt (NaCl-EDTA) washing step and the modified protocols were found to efficiently remove PCR inhibitors from the clinical specimens and subsequently improved the diagnostic sensitivity (DSe) of the qPCR assays. The choice of PCR kit(DNA polymerase) also had a large impact on the DSe (CaPVqPCR) due to the differences in their tolerance against the PCR inhibitors.